Viewing Study NCT01199757


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2026-01-02 @ 9:42 AM
Study NCT ID: NCT01199757
Status: COMPLETED
Last Update Posted: 2017-08-14
First Post: 2010-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module